The India Brand Equity Foundation (IBEF) has compiled findings and released an overview of the current generics market in India. According to its findings, the Indian market has seen an increase manufacturing innovation and development technologies as a result of generics production.   IBEF maintains that during the past three years, pharma exports (largely generics) have grown 22% (CAGR), accounting for more than $13 billion in annual sales. Also, according to IBEF, 40% of ANDAs received by the...